SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-057791
Filing Date
2020-05-07
Accepted
2020-05-07 08:31:38
Documents
79
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014537d1_10q.htm 10-Q 696951
2 EXHIBIT 31.1 tm2014537d1_ex31-1.htm EX-31.1 11167
3 EXHIBIT 31.2 tm2014537d1_ex31-2.htm EX-31.2 10856
4 EXHIBIT 32.1 tm2014537d1_ex32-1.htm EX-32.1 5947
  Complete submission text file 0001104659-20-057791.txt   6610446

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20200331.xml EX-101.INS 1799018
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20200331.xsd EX-101.SCH 56698
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20200331_cal.xml EX-101.CAL 58658
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20200331_def.xml EX-101.DEF 219458
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20200331_lab.xml EX-101.LAB 407580
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20200331_pre.xml EX-101.PRE 393011
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 20854714
SIC: 2834 Pharmaceutical Preparations